Teva Announces tomy's Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelocytic Leukemia (APL) in Rome, Italy | Business Wire
OMACETAXINE MEPESUCCINATE SHOWS ACTIVITY IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO HAVE BECOME RESISTANT TO OR INTOLERANT OF PRIOR TYROSINE KINASE INHIBITORS (TKIs) (1,2,3)
Intas Pharmaceuticals: Intas eyes Teva's oncology, women's health divisions in Europe - The Economic Times
Teva Must Clear Three Big Hurdles to Reclaim Its Perch - TheStreet
Teva's Q3 triumph: 7% revenue surge propelled by Austedo and Ajovy
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva-Acquire-Generics-Rival
2020 – Medical Advertising Hall of Fame
Cerberus, Advent Eye Teva's European Assets, Report Says | Ctech
Teva Pharmaceuticals - Wikipedia
Teva - Latest teva , Information & Updates - Health -ET HealthWorld
Teva Pharmaceuticals Europe - Let's talk about sex and cancer: Woet L. Gianotten provides the much needed talk how to handle this subject with patients. Streaming now on our #BeCOn2017 webinar: http://bit.ly/BeCon2017_LIVE
CVC Nears Deal for Teva's European Women's Health Assets - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva Transplant - Speed Donating | Clios
Teva's migraine drug Ajovy secures European marketing approval
Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Sells Off Last of Specialty Global Women's Health Portfolio Assets in $1.38 Billion Deal
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission - The Lancet Oncology
TEVA Oncology Shines with Experiential Tradeshow Booths - kubik
Teva Europe on X: "BeCOn OWN, a ground-breaking European initiative focusing on the challenges faced by people with cancer and healthcare professionals, takes place on November 29th. If you're a HCP and
